Shareholders elected incumbent nominees to the Board of Salarius Pharmaceuticals (SLRX)
Updated: Dec 31, 2024
Want to read more?
Subscribe to snowballresearch.com to keep reading this exclusive post.
Recent Posts
See AllKey Summary: On December 20, 2024, Gate City Capital Management (6.37%) urged the Board to address underperformance by adopting measures...
INDEX Baron Capital Group opposes the proposed "going private" transaction of FIGS, Inc (FIGS) BML Investment Partners (9.9%) opposes...
Key Summary: On December 31, 2024, BML Investment Partners (9.9%) opposes the proposed PIPE transaction Market Cap: $77 million | ...